首页 | 本学科首页   官方微博 | 高级检索  
检索        

吉非替尼对肺癌细胞生长的抑制作用
引用本文:张贺龙,温华.吉非替尼对肺癌细胞生长的抑制作用[J].现代肿瘤医学,2006,14(4):408-409.
作者姓名:张贺龙  温华
作者单位:1. 第四军医大学唐都医院肿瘤科,陕西,西安,710038
2. 中国医科大学附属第一医院呼吸科,辽宁,沈阳,110001
摘    要:目的探讨靶向治疗药物吉非替尼(ZD1839)对肺癌细胞生长的抑制作用。方法应用细胞培养和MTT等方法研究了ZD1839对13株人肺癌细胞生长的抑制作用。结果在13株肺癌细胞中,有一株肺癌细胞PC-9对ZD1839高度敏感,一株肺癌细胞A549中度敏感,有效率15.38%。其余11株肺癌细胞对ZD1839不敏感。结论吉非替尼是一种新型有效的肺癌分子靶向治疗药物。

关 键 词:肺癌  靶向治疗  吉非替尼
文章编号:1672-4992-(2006)04-0408-02
收稿时间:2005-09-01
修稿时间:2005-12-13

Effect of ZD1839 on the proliferation of lung cancer cells
ZHANG He-long,WEN Hua.Effect of ZD1839 on the proliferation of lung cancer cells[J].Journal of Modern Oncology,2006,14(4):408-409.
Authors:ZHANG He-long  WEN Hua
Abstract:Objective To study the effect of targeted drug ZD1839 on the proliferation of lung cancer cells. Methods Cell culture and MTT assay were used to study the effects of ZD1839 on 13 kinds of lung cancer cells. Results There was only one lung cancer cell PC-9 that was very sensitive to ZD1839, another one A549 was moderate sensitive to ZD1839. The sensitivity was 15.38%. The other 11 lung cancer cells were not sensitive. Conclusion ZD1839 is an effective targeted drug in the treatment of lung cancer. In order to realize the individual chemotherapy of the drug, more studies need to be done.
Keywords:lung cancer  targeted treatment  ZD1839  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号